Healthcare Infographics to Increase the Visibility of Advanced Medical Nutrition Market

The Advanced Medical Nutrition Market is slated to grow unstoppably in the years to come. The healthcare providers are, of late, making way for more specialized and timely treatment through same-day surgeries, outpatient surgeries, and likewise. ASCs (Ambulatory Surgical Centers) are preferred over conventional hospital settings. As such, cost-effective medical services could be provided. This type of customization is expected to take the healthcare vertical by storm in the future.

"Medical Nutrition Market: Global Industry Analysis (2012-2016) and Forecast 2017-2025," a new report by Persistence Market Research concentrates on the parenteral nutrition segment and its overall performance in the global medical nutrition market for the duration of eight years. The report segments the global parenterally administered medical nutrition market on the basis of product type, distribution channel, nutrition type and region.

This segment is divided into Amino Acid Solution, Multiple Vitamins and Antioxidants, Lipid Emulsion, Trace Elements, 2C Bags, and 3C Bags. The Amino Acid Solution segment dominated the global parenteral medical nutrition market in terms of revenue in 2016, and the trend is projected to grow throughout the forecast period. Amino Acid Solution segment is the most attractive segment, with a market attractiveness index of 1.8 over the forecast period.

Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/16588

Hospital Pharmacies, Retail Pharmacies, Compound Pharmacies are the sub-segments in this category. The Retail Pharmacies segment is expected to be the second most lucrative market in the global parenteral nutrition market by distribution channel, with an attractiveness index of 0.5 during the forecast period. The Retail Pharmacies segment is estimated to account for 13.1% value share in 2017. Hospital Pharmacies will hold the largest market share of more than 65% throughout the forecast period.

Company Profiles:

Allergan
Baxter International Inc.
Braun Melsungen AG.
Fresenius Kabi AG
Pfizer, Inc.
Sanofi
Mead Johnson & Company, LLC
Sichuan Kelun Pharmaceutical Company Limited
Otsuka Pharmaceuticals Co., Ltd.
Grifols S.A.
Abbott Laboratories
Danone Nutricia
Demo S.A. Pharmaceutical Industry
Others.

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/16588

The global parenterally administered medical nutrition market is estimated to represent incremental opportunity of US$ 2,577.4 Mn between 2017 and 2025. The market is expected to grow from US$ 3,468.9 Mn in 2017 to US$ 6,046.3 Mn by 2025 end. This represents a CAGR of 7.2% over the forecast period.

Access Full Report@ https://www.persistencemarketresearch.com/checkout/16588

The North America region dominated the global parenteral medical nutrition market in terms of revenue in 2016, and the trend is projected to grow throughout the forecast period. North America is the most attractive regional market, with an attractiveness index of 2.2 over the forecast period. Revenue from the North America regional market is anticipated to increase at a CAGR of 8.7% over 2017-2025, to reach US$ 2,365.9 Mn by 2025.

Access Related Reports-

Fluid Warmer Devices Market: https://www.persistencemarketresearch.com/market-research/fluid-warmer-devices-market.asp

Single Domain Antibody Platforms Market: https://www.persistencemarketresearch.com/market-research/single-domain-antibody-platforms-market.asp

Contact Us:

Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
Website - https://www.persistencemarketresearch.com

About Us:

Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.

This release was published on openPR.